Steven Shoelson
Professor of Medicine , Joslin Diabetes Center
Location: United States
Consulting Services
Areas Of Interest
Professional Narrative
Dr. Shoelson’s interests include developing new treatment strategies based on underlying pathophysiology and the pathophysiology of insulin resistance and diabetes. His laboratory identifies physiological and pathological mechanisms in metabolism with the potential for development of new therapeutics. Through a series of basic and clinical studies (TINSAL-T2D) his showed that salicylate, the world’s oldest anti-inflammatory drug, lowers blood sugar and lipids in patients with diabetes.
Employment
Education
Referees
Publications
Grants,Awards and Certifications
Grants :
No Grants Mentioned !!
Awards & Prizes :
